Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Summary of Warrants Outstanding (Details)

v3.22.2
Stockholders' Equity - Summary of Warrants Outstanding (Details)
9 Months Ended
May 31, 2022
$ / shares
shares
Number of shares  
Number of shares outstanding, beginning balance (in shares) | shares 9,592,085
Issued (in shares) | shares 22,470,104
Cancelled (in shares) | shares 0
Exercised (in shares) | shares (9,621,964)
Number of shares outstanding, ending balance (in shares) | shares 22,440,225
Number of shares exercisable (in shares) | shares 12,167,143
Weighted average remaining life (years)  
Weighted remaining life (years), beginning 4 years 8 months 12 days
Issued 3 years 9 months 18 days
(Cancelled) 0 years
(Exercised) 2 years 2 months 12 days
Weighted remaining life (years), ending 4 years 6 months
Weighted remaining life (years) exercisable 3 years 10 months 24 days
Weighted average exercise price  
Weighted average exercise prices, beginning (in dollars per share) | $ / shares $ 3.87
Issued (in dollars per share) | $ / shares 1.58
Cancelled (in dollars per share) | $ / shares 0
Exercised (in dollars per share) | $ / shares 0.6
Weighted average exercise prices, ending (in dollars per share) | $ / shares 2.35
Weighted average exercise price exercisable (in dollars per share) | $ / shares $ 1.32